Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
This is a phase II study in previously untreated subjects with histologically or
cytologically proven stage IIIB/IV NSCLC designed to determine the efficacy of first line
treatment with carboplatin and cetuximab.